Technical Analysis for ROSGQ - Rosetta Genomics Ltd
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Crossed Above 50 DMA | Bullish | 0.00% | |
Volume Surge | Other | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 233.33% | |
Narrow Range Bar | Range Contraction | 233.33% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. |
Get this analysis on your stocks daily!
Rosetta Genomics Ltd Description
Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company's microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay that is intended for use in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer; and ERG/PTEN, which are FISH-based prognostic tests in prostate cancer. In addition, the company offers ALK/ROS1 that are FISH-based predictive tests indicated for patients who are diagnosed with late stage lung cancer; and PCR gene mutation analysis for bladder, lung, colon, and melanoma patients. The company provides its diagnostic solutions for oncologists, urologists, endocrinologists, cytopathologists, and other specialists to facilitate them in serving their patients. It has a license agreement with Max Planck Innovation GmbH for the rights to its proprietary microRNAs for diagnostics and research purposes. The company also has a collaboration agreement with Meir Medical Center to develop a microRNA classifier relating to patients with non-small cell lung cancer considered for treatment with immuno oncology drugs. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Nose Prostate Cancer Oncology Kidney Diagnostic Tests Small Cell Genomics Urine Lung Cancer Pathology Tumor Aspi Carcinoma Infectious Causes Of Cancer Fluorescence Genetics Melanoma Non Small Cell Lung Cancer Thyroid Bladder Cancer Small Cell Lung Cancer Diagnostic Solutions Metastatic Cancer Hybridization Mutation Fluorescence In Situ Hybridization Hematuria In Situ Hybridization Microrna Rehovot
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Date | Title |
---|
Indicator | Value |
---|---|
52 Week High | 0.39 |
52 Week Low | 0.0001 |
Average Volume | 9,002 |
200-Day Moving Average | 0.0473 |
50-Day Moving Average | 0.0005 |
20-Day Moving Average | 0.0003 |
10-Day Moving Average | 0.0002 |
Average True Range | 0.0007 |
RSI | 51.92 |
ADX | 29.86 |
+DI | 55.0000 |
-DI | 25.0000 |
Chandelier Exit (Long, 3 ATRs) | -0.0010 |
Chandelier Exit (Short, 3 ATRs) | 0.0022 |
Upper Bollinger Bands | 0.0010 |
Lower Bollinger Band | -0.0004 |
Percent B (%b) | 1.0 |
BandWidth | 466.6667 |
MACD Line | -0.0002 |
MACD Signal Line | -0.0004 |
MACD Histogram | 0.0002 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.0010 | ||||
Resistance 3 (R3) | 0.0010 | 0.0010 | 0.0010 | ||
Resistance 2 (R2) | 0.0010 | 0.0010 | 0.0010 | 0.0010 | |
Resistance 1 (R1) | 0.0010 | 0.0010 | 0.0010 | 0.0010 | 0.0010 |
Pivot Point | 0.0010 | 0.0010 | 0.0010 | 0.0010 | 0.0010 |
Support 1 (S1) | 0.0010 | 0.0010 | 0.0010 | 0.0010 | 0.0010 |
Support 2 (S2) | 0.0010 | 0.0010 | 0.0010 | 0.0010 | |
Support 3 (S3) | 0.0010 | 0.0010 | 0.0010 | ||
Support 4 (S4) | 0.0010 |